ArticleCancer biomarkers : section A of Disease markers2018

Recombinant adenovirus p53 combined with radiotherapy improves efficacy and safety in the treatment of head and neck lymphoma.

Yong-Hua Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.